Correction of fragile X syndrome in mice
- PMID: 18093519
- PMCID: PMC2199268
- DOI: 10.1016/j.neuron.2007.12.001
Correction of fragile X syndrome in mice
Abstract
Fragile X syndrome (FXS) is the most common form of heritable mental retardation and the leading identified cause of autism. FXS is caused by transcriptional silencing of the FMR1 gene that encodes the fragile X mental retardation protein (FMRP), but the pathogenesis of the disease is unknown. According to one proposal, many psychiatric and neurological symptoms of FXS result from unchecked activation of mGluR5, a metabotropic glutamate receptor. To test this idea we generated Fmr1 mutant mice with a 50% reduction in mGluR5 expression and studied a range of phenotypes with relevance to the human disorder. Our results demonstrate that mGluR5 contributes significantly to the pathogenesis of the disease, a finding that has significant therapeutic implications for fragile X and related developmental disorders.
Figures
Comment in
-
The fragile X mental retardation protein: a valuable partner in the battle against epileptogenesis.Epilepsy Curr. 2009 Jul-Aug;9(4):116-8. doi: 10.1111/j.1535-7511.2009.01311.x. Epilepsy Curr. 2009. PMID: 19693330 Free PMC article. No abstract available.
References
-
- Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004;27:370–377. - PubMed
-
- Bjarnadottir TK, Schioth HB, Fredriksson R. The phylogenetic relationship of the glutamate and pheromone G-protein-coupled receptors in different vertebrate species. Ann N Y Acad Sci. 2005;1040:230–233. - PubMed
-
- Brown V, Jin P, Ceman S, Darnell JC, O’Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 2001;107:477–487. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
